{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T16:07:39Z","timestamp":1744387659156},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Requirements Eng"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00766-024-00426-1","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T08:01:51Z","timestamp":1721289711000},"page":"357-369","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Navigating personalized medication: unveiling user needs to forge a cutting-edge platform for proactive prevention and monitoring of adverse drug reactions"],"prefix":"10.1007","volume":"29","author":[{"given":"Aulia-Absari","family":"Khalil","sequence":"first","affiliation":[]},{"given":"Ford Lumban","family":"Gaol","sequence":"additional","affiliation":[]},{"given":"Boy Subirosa","family":"Sabarguna","sequence":"additional","affiliation":[]},{"given":"Harjanto","family":"Prabowo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"key":"426_CR1","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1111\/bcp.13081","volume":"82","author":"SL Chan","year":"2016","unstructured":"Chan SL, Ang X, Sani LL et al (2016) Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study. Br J Clin Pharmacol 82:1636\u20131646. https:\/\/doi.org\/10.1111\/bcp.13081","journal-title":"Br J Clin Pharmacol"},{"key":"426_CR2","doi-asserted-by":"publisher","first-page":"e0282096","DOI":"10.1371\/journal.pone.0282096","volume":"18","author":"AK Sendekie","year":"2023","unstructured":"Sendekie AK, Netere AK, Tesfaye S et al (2023) Incidence and patterns of adverse drug reactions among adult patients hospitalized in the University of Gondar comprehensive specialized hospital: a prospective observational follow-up study. PLoS ONE 18:e0282096. https:\/\/doi.org\/10.1371\/journal.pone.0282096","journal-title":"PLoS ONE"},{"key":"426_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.7861\/clinmedicine.16-5-481","volume":"16","author":"JJ Coleman","year":"2016","unstructured":"Coleman JJ, Pontefract SK (2016) Adverse drug reactions. Clin Med 16:481\u2013485. https:\/\/doi.org\/10.7861\/clinmedicine.16-5-481","journal-title":"Clin Med"},{"key":"426_CR4","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1542\/peds.111.4.722","volume":"111","author":"EB Fortescue","year":"2003","unstructured":"Fortescue EB, Kaushal R, Landrigan CP et al (2003) Prioritizing strategies for preventing medication errors and adverse drug events in Pediatric inpatients. Pediatrics 111:722\u2013729. https:\/\/doi.org\/10.1542\/peds.111.4.722","journal-title":"Pediatrics"},{"key":"426_CR5","first-page":"560","volume":"35","author":"FR Vogenberg","year":"2010","unstructured":"Vogenberg FR, Isaacson Barash C, Pursel M (2010) Personalized medicine: part 1: evolution and development into theranostics. P T 35:560\u2013576","journal-title":"P T"},{"key":"426_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/amiajnl-2012-000892","volume":"20","author":"BM Welch","year":"2013","unstructured":"Welch BM, Kawamoto K (2013) Clinical decision support for genetically guided personalized medicine: a systematic review. J Am Med Inform Assoc 20:388\u2013400. https:\/\/doi.org\/10.1136\/amiajnl-2012-000892","journal-title":"J Am Med Inform Assoc"},{"key":"426_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1089\/tmj.2012.0136","volume":"19","author":"KY-L Yap","year":"2013","unstructured":"Yap KY-L, Low HX, Koh KS et al (2013) Feasibility and Acceptance of a Pharmacist-Run Tele-Oncology Service for Chemotherapy-Induced nausea and vomiting in Ambulatory Cancer patients. Telemedicine e-Health 19:387\u2013395. https:\/\/doi.org\/10.1089\/tmj.2012.0136","journal-title":"Telemedicine e-Health"},{"key":"426_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/phar.1896","volume":"37","author":"SR Dorajoo","year":"2017","unstructured":"Dorajoo SR, See V, Chan CT et al (2017) Identifying potentially avoidable readmissions: a medication-based 15-Day readmission risk stratification algorithm. Pharmacotherapy: J Hum Pharmacol Drug Therapy 37:268\u2013277. https:\/\/doi.org\/10.1002\/phar.1896","journal-title":"Pharmacotherapy: J Hum Pharmacol Drug Therapy"},{"key":"426_CR9","doi-asserted-by":"crossref","unstructured":"Khalil A-A, Lumban Gaol F, Subirosa Sabarguna B, Prabowo H (2021) IT Solutions for Preventing and Monitoring Adverse Drug Reactions: A Systematic Literature Review. In: 2021 5th International Conference on Computational Biology and Bioinformatics. ACM, New York, NY, USA, pp 56\u201361","DOI":"10.1145\/3512452.3512460"},{"key":"426_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/ebmental-2019-300086","volume":"22","author":"C Henshall","year":"2019","unstructured":"Henshall C, Cipriani A, Ruvolo D et al (2019) Implementing a digital clinical decision support tool for side effects of antipsychotics: a focus group study. Evid Based Mental Health 22:56\u201360. https:\/\/doi.org\/10.1136\/ebmental-2019-300086","journal-title":"Evid Based Mental Health"},{"key":"426_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40266-019-00728-y","volume":"37","author":"LGM Mulder-Wildemors","year":"2020","unstructured":"Mulder-Wildemors LGM, Heringa M, Floor-Schreudering A et al (2020) Reducing Inappropriate Drug Use in older patients by Use of clinical decision support in Community Pharmacy: a mixed-methods evaluation. Drugs Aging 37:115\u2013123. https:\/\/doi.org\/10.1007\/s40266-019-00728-y","journal-title":"Drugs Aging"},{"key":"426_CR12","first-page":"128","volume":"236","author":"A Shoshi","year":"2017","unstructured":"Shoshi A, M\u00fcller U, Shoshi A et al (2017) KALIS - An eHealth System for Biomedical Risk Analysis of Drugs. Stud Health Technol Inf 236:128\u2013135","journal-title":"Stud Health Technol Inf"},{"key":"426_CR13","doi-asserted-by":"publisher","unstructured":"Roncato R, Dal Cin L, Mezzalira S et al (2019) FARMAPRICE: A Pharmacogenetic Clinical Decision Support System for Precise and Cost-Effective Therapy. Genes (Basel) 10:. https:\/\/doi.org\/10.3390\/genes10040276","DOI":"10.3390\/genes10040276"},{"key":"426_CR14","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.jacc.2015.12.063","volume":"67","author":"PJ Schwartz","year":"2016","unstructured":"Schwartz PJ, Woosley RL (2016) Predicting the unpredictable. J Am Coll Cardiol 67:1639\u20131650. https:\/\/doi.org\/10.1016\/j.jacc.2015.12.063","journal-title":"J Am Coll Cardiol"},{"key":"426_CR15","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.2196\/medinform.9064","volume":"6","author":"C-Y Yang","year":"2018","unstructured":"Yang C-Y, Lo Y-S, Chen R-J, Liu C-T (2018) A clinical decision support engine based on a National Medication Repository for the detection of potential duplicate medications: design and evaluation. JMIR Med Inf 6:e6. https:\/\/doi.org\/10.2196\/medinform.9064","journal-title":"JMIR Med Inf"},{"key":"426_CR16","doi-asserted-by":"crossref","unstructured":"Bajenaru L, Marinescu IA, Dobre C et al (2020) Towards the development of a personalized healthcare solution for elderly: from user needs to system specifications. In: 2020 12th International Conference on Electronics, Computers and Artificial Intelligence (ECAI). IEEE, pp 1\u20136","DOI":"10.1109\/ECAI50035.2020.9223254"},{"key":"426_CR17","doi-asserted-by":"publisher","unstructured":"IANCULESCU M, ALEXANDRU A (2016) Silver Digital Patient, a New Emerging Stakeholder in Current Healthcare. ProActiveAgeing: a Case Study. Stud Inf Control 25. https:\/\/doi.org\/10.24846\/v25i4y201607","DOI":"10.24846\/v25i4y201607"},{"key":"426_CR18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1186\/2193-1801-3-695","volume":"3","author":"RK Sahu","year":"2014","unstructured":"Sahu RK, Yadav R, Prasad P et al (2014) Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance. Springerplus 3:695. https:\/\/doi.org\/10.1186\/2193-1801-3-695","journal-title":"Springerplus"},{"key":"426_CR19","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255\u20131259. https:\/\/doi.org\/10.1016\/S0140-6736(00)02799-9","journal-title":"Lancet"},{"key":"426_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/ajd.12803","volume":"59","author":"S Charlston","year":"2018","unstructured":"Charlston S, Siller G (2018) Teledermatologist expert skin advice: a unique model of care for managing skin disorders and adverse drug reactions in hepatitis C patients. Australas J Dermatol 59:315\u2013317. https:\/\/doi.org\/10.1111\/ajd.12803","journal-title":"Australas J Dermatol"},{"key":"426_CR21","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1080\/10428194.2018.1551540","volume":"60","author":"AC Copeland","year":"2019","unstructured":"Copeland AC, Foster MC, Muluneh B et al (2019) The utility of a telemedicine platform to monitor adherence and adverse effects of tyrosine kinase inhibitors. Leuk Lymphoma 60:1842\u20131844. https:\/\/doi.org\/10.1080\/10428194.2018.1551540","journal-title":"Leuk Lymphoma"},{"key":"426_CR22","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.2196\/mhealth.6261","volume":"5","author":"M Ithnin","year":"2017","unstructured":"Ithnin M, Mohd Rani MD, Abd Latif Z et al (2017) Mobile App Design, Development, and publication for adverse drug reaction assessments of causality, severity, and preventability. JMIR Mhealth Uhealth 5:e78. https:\/\/doi.org\/10.2196\/mhealth.6261","journal-title":"JMIR Mhealth Uhealth"},{"key":"426_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/2042098618769565","volume":"9","author":"CS Jabaley","year":"2018","unstructured":"Jabaley CS, Wolf FA, Lynde GC, O\u2019Reilly-Shah VN (2018) Crowdsourcing sugammadex adverse event rates using an in-app survey: feasibility assessment from an observational study. Ther Adv Drug Saf 9:331\u2013342. https:\/\/doi.org\/10.1177\/2042098618769565","journal-title":"Ther Adv Drug Saf"},{"key":"426_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3233\/SHTI200530","volume":"272","author":"A Kulenovic","year":"2020","unstructured":"Kulenovic A, Lagumdzija-Kulenovic A (2020) Using PM-TOM for the minimization of adverse drug and Gene Interactions in therapies for common multi-diseases. Stud Health Technol Inf 272:205\u2013208. https:\/\/doi.org\/10.3233\/SHTI200530","journal-title":"Stud Health Technol Inf"},{"key":"426_CR25","doi-asserted-by":"crossref","unstructured":"Kujala S, Kauppinen M (2004) Identifying and selecting users for user-centered design. In: Proceedings of the third Nordic conference on Human-computer interaction - NordiCHI \u201904. ACM Press, New York, New York, USA, pp 297\u2013303","DOI":"10.1145\/1028014.1028060"},{"key":"426_CR26","doi-asserted-by":"crossref","unstructured":"Maguire M, Bevan N (2002) User Requirements Analysis. pp 133\u2013148","DOI":"10.1007\/978-0-387-35610-5_9"}],"container-title":["Requirements Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00766-024-00426-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00766-024-00426-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00766-024-00426-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T06:07:04Z","timestamp":1724738824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00766-024-00426-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["426"],"URL":"https:\/\/doi.org\/10.1007\/s00766-024-00426-1","relation":{},"ISSN":["0947-3602","1432-010X"],"issn-type":[{"type":"print","value":"0947-3602"},{"type":"electronic","value":"1432-010X"}],"subject":[],"published":{"date-parts":[[2024,7,18]]},"assertion":[{"value":"24 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not sought for the present study. Due to the content of the questionnaire and the anonymous data processing, no implications could be identified.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all interview participants through written communication via email and from questionnaire respondents via survey software. They were explicitly informed that their data would be used solely for research purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The manuscript doesn\u2019t contain any individual person\u2019s data. Qualitative and quantitative data have been anonymized.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}